David M. Haig

Nottingham, ENG NG72UH, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecoviruses.

An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecoviruses.

Journal: bioRxiv : the preprint server for biology

Published: August 12, 2025

Increased Clinical Signs and Mortality in IFNAR(-/-) Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype.

Increased Clinical Signs and Mortality in IFNAR(-/-) Mice Immunised with the Bluetongue Virus Outer-Capsid Proteins VP2 or VP5, after Challenge with an Attenuated Heterologous Serotype.

Journal: Pathogens (Basel, Switzerland)

Published: February 24, 2023

Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes.

Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes.

Journal: Viruses

Published: June 05, 2021

Analysis of immune responses to attenuated alcelaphine herpesvirus 1 formulated with and without adjuvant.

Analysis of immune responses to attenuated alcelaphine herpesvirus 1 formulated with and without adjuvant.

Journal: Vaccine: X

Published: February 04, 2021

A host-independent role for Fasciola hepatica transforming growth factor-like molecule in parasite development.

A host-independent role for Fasciola hepatica transforming growth factor-like molecule in parasite development.

Journal: International journal for parasitology

Published: August 28, 2020

Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules.

Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules.

Journal: Veterinary immunology and immunopathology

Published: July 22, 2016

The efficacy of alcelaphine herpesvirus-1 (AlHV-1) immunization with the adjuvants Emulsigen® and the monomeric TLR5 ligand FliC in zebu cattle against AlHV-1 malignant catarrhal fever induced by experimental virus challenge.

The efficacy of alcelaphine herpesvirus-1 (AlHV-1) immunization with the adjuvants Emulsigen® and the monomeric TLR5 ligand FliC in zebu cattle against AlHV-1 malignant catarrhal fever induced by experimental virus challenge.

Journal: Veterinary microbiology

Published: June 23, 2016

Alcelaphine herpesvirus 1 glycoprotein B: recombinant expression and antibody recognition.

Alcelaphine herpesvirus 1 glycoprotein B: recombinant expression and antibody recognition.

Journal: Archives of virology

Published: September 18, 2015

A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.

A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.

Journal: Vaccine

Published: September 15, 2015

Alcelaphine Herpesvirus-1 (Malignant Catarrhal Fever Virus) in Wildebeest Placenta: Genetic Variation of ORF50 and A9.5 Alleles.

Alcelaphine Herpesvirus-1 (Malignant Catarrhal Fever Virus) in Wildebeest Placenta: Genetic Variation of ORF50 and A9.5 Alleles.

Journal: PloS one

Published: December 08, 2014

Susceptibility to experimental infection of the invertebrate locusts (Schistocerca gregaria) with the apicomplexan parasite Neospora caninum.

Susceptibility to experimental infection of the invertebrate locusts (Schistocerca gregaria) with the apicomplexan parasite Neospora caninum.

Journal: PeerJ

Published: July 11, 2014

Identification of immuno-reactive capsid proteins of malignant catarrhal fever viruses.

Identification of immuno-reactive capsid proteins of malignant catarrhal fever viruses.

Journal: Veterinary microbiology

Published: April 28, 2014

Showing 1-12 of 22

Last Updated: 09/26/2026